Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians

Arthritis and Rheumatism

Volumn 54, Issue 12, 2006, Pages 3979-3987

  Mamyrova, Gulnara ^a   O'Hanlon, Terrance P ^a   Monroe, Jason B ^a   Carrick, Danielle Mercatante ^a   Malley, James D ^b   Adams, Sharon ^c   Reed, Ann M ^d   Shamim, Ejaz A ^a   James Newton, Laura ^a   Miller, Frederick W ^a   Rider, Lisa G ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CAUCASIAN; DERMATOMYOSITIS; GENETIC RISK; HLA TYPING; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; BINDING SITES; DERMATOMYOSITIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ODDS RATIO; RISK FACTORS;

EID: 33845599505     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22216     Document Type: Article

References (31)

1. Rider LG, Targoff IN. Muscle diseases. In: Lahita RG, Chiorazzi N, Reeves WH, editors. Textbook of the autoimmune diseases. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 429-74.
2. Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:891-916.
3. Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000; 12:482-91.
4. Rider LG, Miller FW. Idiopathic inflammatory muscle disease: clinical aspects. Bailliere's Best Pract Res Clin Rheumatol 2000; 14:37-54.
5. Fall N, Bove KE, Stringer K, Lovell DJ, Brunner HI, Weiss J, et al. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy. Arthritis Rheum 2005;52:3175-80.
6. O'Hanlon TP, Carrick DM, Arnett FC, Reveille JD, Carrington M, Gao X, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine (Baltimore) 2005;84: 338-49.
7. Lie BA, Thorsby E. Several genes in the extended human MHC contributed to predisposition to autoimmune disease. Curr Opin Immunol 2005;17:526-31.
8. Chinoy H, Salway F, Fertig N, Shephard N, Tait BD, Thomson W, et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype [online]. Arthritis Res Ther 2005;8:R13.
9. Reed AM, Pachman L, Ober C. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1*0501. Hum Immunol 1991;32:235-40.
10. Reed AM, Stirling JD. Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis. Hum Immunol 1995;44:131-5.
11. Reed AM, Pachman LM, Hayford J, Ober C. Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 1998;25:1000-2.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
13. Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol 2003; 64:930-5.
14. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:65-70.
15. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18-27.
16. O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006;85:111-27.
17. Friedman JM, Pachman LM, Maryjowski ML, Radvany RM, Crowe WE, Hanson V, et al. Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies. Arthritis Rheum 1983;26:214-6.
18. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol 2005;14:175-82.
19. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996;39:1507-18.
20. Price P, Witt CA, Allcock R, Sayer D, Garlepp M, Kok CC, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999;167:257-74.
21. Rider LG, Gurley RC, Pandey JP, Garcia-de la Torre I, Kalovidouris AE, O'Hanlon TP, et al. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum 1998;41:710-9.
22. Glass DN, Gianini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 1999;11:2261-8.
23. Murray KJ, Moroldo MB, Donelly P, Prahalad S, Passo MH, Gianini EH, et al. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum 1999;42: 1843-53.
24. Sabbah E, Savola K, Ebeling T, Kulmala P, Vahasalo P, Ilonen J, et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000;23: 1326-32.
25. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005;66:301-13.
26. Ettinger RA, Kwok W. A peptide binding motif for HLA-DQA1*0102/ DRB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J Immunol 1998;160:2365-73.
27. Routsias J, Papadopoulos GK. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM. Diabetologia 1995;38:1251-61.
28. Hoover ML, Marta RT. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Scand J Immunol 1997;45:193-202.
29. Pachman LM, Hayford JR, Hochberg MC, Pallansch MA, Chung A, Daugherty CD, et al. New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40:1526-33.
30. Patrick M, Buchbinder R, Jolley D, Dennett X, Buchanan R. Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J Rheumatol 1999;26: 1094-100.
31. Petrone A, Bugawan TL, Mesturino CA, Nistico L, Galgani A, Giorgi G, et al. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type I diabetes in continental Italy (Lazio region). Tissue Antigens 2001;58:385-94.